ARID2 and cervical carcinoma: To identify the effect of ARID2 in cervical cancer, we knocked down ARID2 expression in CaSki cells using targeting siRNAs, and the siRNA interference efficiency was determined by qRT-PCR and immunoblotting analyses (Supplementary Fig. 1B).